Liposomal Supplement Brand Hits $150M Revenue with 300% Absorption Tech in Whole Foods and Ulta
TGT•The rapidly growing liposomal supplement brand scaled to $150M annual revenue, expanded distribution from direct-to-consumer to include Target since October and recently Whole Foods and Ulta. Its patent-pending liposomal packets demonstrated 300% higher glutathione absorption in recent clinicals, with products priced $40–$90.
1. Retail Expansion to Target, Whole Foods and Ulta
The supplement brand moved beyond direct-to-consumer after bootstrapping $150M in annual revenue, launching in Target in October and securing shelf space at Whole Foods and Ulta. Additional major retail partnerships are reportedly in negotiation, marking a shift to omnichannel distribution.
2. Patent-Pending Liposomal Technology and Clinicals
Products leverage liposomal encapsulation to boost nutrient absorption, with April clinicals showing a flagship glutathione formula achieves 300% higher uptake versus standard. The company holds patent-pending status on its delivery packets and anticipates patent grants soon, reinforcing its competitive edge.
3. Bootstrapped $150M Revenue and Pricing Strategy
The company reached $150M in annual revenue through direct sales before retail rollout, offering 32 SKUs of high-end supplements. Price points range from $40 to the high $90s per packet, targeting consumers prioritizing premium wellness products over conventional capsules or gummies.
